Skip to main content
. 2011 Dec 19;30(3):322–328. doi: 10.1200/JCO.2011.37.5394

Fig A1.

Fig A1.

(A) Distribution of baseline C-reactive protein (CRP) by clinical benefit (complete response [CR]/partial response [PR]/stable disease [SD] v progression of disease [PD]) and (B) the probability of survival (CRP, ≤ 2.7× v > 2.7× the upper limit of normal [ULN]).